Diabetes mellitus (DM) and cardiovascular complications are two unmet medical
emergencies that can occur together. The rising incidence of heart failure in diabetic …

Background Despite the widespread use of classical cholesterol-lowering drugs to mitigate
the adverse impacts of dyslipidaemia on atherosclerosis, many patients still face a …

Dyslipidaemia plays a prominent role in the genesis of atherosclerotic plaque and the
increased cardiovascular risk in diabetes. Macrophages readily take up atherogenic …

Diabetic kidney disease (DKD) is a major cause of chronic kidney disease (CKD), and it
heightens the risk of cardiovascular incidents. The pathogenesis of DKD is thought to …

Diabetes and chronic liver and kidney disease are common long-term conditions worldwide.
Taraxacum officinale (TOE) has many medicinal properties, due to it phytochemicals …

Diabetic nephropathy is a severe complication of diabetes. Treatment of diabetic
nephropathy is an important challenge due to persistent hyperglycemia and elevated levels …

Sodium-glucose co-transporter-2 (SGLT-2) inhibitors, a class of drugs primarily designed for
the treatment of type 2 diabetes mellitus (T2DM), received their first approval for use by the …

Diabetic kidney disease (DKD) is one of the chronic microvascular complications caused by
diabetes, which is characterized by persistent albuminuria and/or progressive decline of …

Despite continuous investigations in the diagnosis and treatment of severe acute
pancreatitis (SAP), this disease still remains a critical condition with a mortality rate of up to …

Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone
Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone J …